Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.44 |
| ▸ | PRKCG | P05129 | 1/20 | 0.44 |
| ▸ | PRKCB | P05771 | 1/20 | 0.44 |
| ▸ | PRKCA | P17252 | 1/20 | 0.44 |
| ▸ | PRKCH | P24723 | 1/20 | 0.44 |
| ▸ | PRKCI | P41743 | 1/20 | 0.44 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.44 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.44 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.44 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.44 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | SLC28A3 | Q9HAS3 | 2/20 | 0.43 |
| ▸ | PYGB | P11216 | 1/20 | 0.43 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.41 |
| ▸ | KDR | P35968 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22439758 | 1.00 | L3MBTL1 (0.45) | L3MBTL1MAPTPRKD3PRKCGPRKCB | |
| SCHEMBL30397543 | 1.00 | L3MBTL1 (0.45) | L3MBTL1MAPTPRKD3PRKCGPRKCB | |
| SCHEMBL3015191 | 1.00 | L3MBTL1 (0.45) | L3MBTL1MAPTPRKD3PRKCGPRKCB | |
| SCHEMBL29357984 | 1.00 | L3MBTL1 (0.45) | L3MBTL1MAPTPRKD3PRKCGPRKCB | |
| SCHEMBL12290512 | 0.89 | L3MBTL1 (0.46) | L3MBTL1MAPTPRKD3PRKCGPRKCB | |
| SCHEMBL8069003 | 0.89 | L3MBTL1 (0.46) | L3MBTL1MAPTPRKD3PRKCGPRKCB | |
| SCHEMBL8136408 | 0.89 | L3MBTL1 (0.46) | L3MBTL1MAPTPRKD3PRKCGPRKCB | |
| SCHEMBL27654959 | 0.89 | L3MBTL1 (0.46) | L3MBTL1MAPTPRKD3PRKCGPRKCB | |
| SCHEMBL2337047 | 0.86 | L3MBTL1 (0.44) | L3MBTL1MAPTPRKD3PRKCGPRKCB | |
| SCHEMBL27865347 | 0.86 | L3MBTL1 (0.44) | L3MBTL1MAPTPRKD3PRKCGPRKCB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116251110-B | Application of beta-D-glucopyranosyl-lactic acid and derivatives thereof in preparation of medicines for treating metabolic diseases and inflammation | 广东药科大学 | 2025-02-14 | — | — | CN | disclosed |
| US-20250051384-A1 | NEUTRAL GLYCOSYLATED AMIDES AND DIANIONIC GLUCURONIDATED ACIDS AS STABILIZERS FOR BIOLOGICAL MOLECULES | EXTREMOCHEM, LDA. (PT) | 2025-02-13 | — | — | US | disclosed |
| US-12098162-B2 | Neutral glycosylated amides and dianionic glucuronidated acids as stabilizers for biological molecules | EXTREMOCHEM, LDA (PT) | 2024-09-24 | — | — | US | disclosed |
| CN-116251110-A | Application of beta-D-glucopyranosyl-lactic acid and derivatives thereof in preparation of medicines for treating metabolic diseases and inflammation | 广东药科大学 | 2023-06-13 | — | — | CN | disclosed |
| US-20220033427-A1 | NEUTRAL GLYCOSYLATED AMIDES AND DIANIONIC GLUCURONIDATED ACIDS AS STABILIZERS FOR BIOLOGICAL MOLECULES | EXTREMOCHEM, LDA (PT) | 2022-02-03 | — | — | US | disclosed |
| EP-3710463-A1 | NEUTRAL GLYCOSYLATED AMIDES AND DIANIONIC GLUCURONIDATED ACIDS AS STABILIZERS FOR BIOLOGICAL MOLECULES | Extremochem, Lda. (PT) | 2020-09-23 | — | — | EP | disclosed |
| CN-111683957-A | Neutral glycosylated amides and dianionic glucuronidated acids as stabilizers for biomolecules | 埃克斯特雷莫凯姆有限公司 | 2020-09-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12098162-B2 | Neutral glycosylated amides and dianionic glucuronidated acids as stabilizers for biological molecules | FUT6, GUSB, UGGT1 | L3MBTL1 3468/4885MAPT 873/4885PRKD3 4285/4885 |
| US-20250051384-A1 | NEUTRAL GLYCOSYLATED AMIDES AND DIANIONIC GLUCURONIDATED ACIDS AS STABILIZERS FOR BIOLOGICAL MOLECULES | FUT6, GUSB, UGGT1 | L3MBTL1 3468/4885MAPT 873/4885PRKD3 4285/4885 |
| US-20220033427-A1 | NEUTRAL GLYCOSYLATED AMIDES AND DIANIONIC GLUCURONIDATED ACIDS AS STABILIZERS FOR BIOLOGICAL MOLECULES | FUT6, GUSB, UGGT1 | L3MBTL1 3468/4885MAPT 873/4885PRKD3 4285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.